Home » Newsletters » BioWorld Science

BioWorld Science

May 3, 2022

View Archived Issues

OQL-051 shows prophylactic efficacy in models of chemotherapy-induced diarrhea

New EGFR inhibitors discovered at the Dana-Farber Cancer Institute

Storm Therapeutics identifies new METTL3 inhibitors

GlaxoSmithKline synthesizes new MRGPRX2 antagonists

Lilly patents dopamine D1 receptor positive allosteric modulators

Serine/threonine-protein kinase Pim-1 inhibitors identified at Japan Tobacco

Allogeneic colorectal cancer vaccine active against anti-PD-1-resistant colon cancer

S trimer-engaging multivalent protein neutralizes SARS-CoV-2 variants and protects mice

Identification of human MAb that broadly neutralizes sarbecoviruses unveils a crucial CDRH3 motif

Hemispherian closes seed funding to advance preclinical pipeline for cancer

Gilead and Dragonfly collaborate to advance NK cell engager-based immunotherapies

ProfoundBio antibody-drug conjugate PRO-1102 shows potency in vitro and in vivo

Ring Therapeutics describes in vitro system enabling human anellovirus production

Novel TRPC5 inhibitors show potential for the treatment of CKD

Tripartite interactions between nervous system, immune cells and plaques drive atherosclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.